TITLE-VIII: RESTRICTIONS ON THE MANUFACTURING, PLACING ON THE MARKET AND USE OF CERTAIN DANGEROUS SUBSTANCES, PREPARATIONS AND ARTICLES
CHAPTER-2: Restrictions process
ARTICLE 69: Preparation of a proposal
Please note that this version of the REACH directive is out of date.
Go to new version now
ARTICLE 69: | Preparation of a proposal |
1. If the Commission considers that the manufacture, placing on the market or use of a substance on its own, in a preparation
or in an article poses a risk to human health or the environment that is not adequately controlled and needs to be addressed,
it shall ask the Agency to prepare a dossier which conforms to the requirements of Annex XV.
2. After the date referred to in Article 58(1)(c)(i) for a substance listed in Annex XIV, the Agency shall consider whether the use of that substance in articles poses a risk to human health or the environment that is not
adequately controlled. If the Agency considers that the risk is not adequately controlled, it shall prepare a dossier which conforms to the requirements of Annex
XV.
3. Within 12 months of the receipt of the request from the Commission in paragraph 1 and if this dossier demonstrates that
action on a Community-wide basis is necessary, beyond any measures already in place, the Agency shall suggest restrictions, in order to initiate the restrictions process.
4. If a Member State considers that the manufacture, placing on the market or use of a substance on its own, in a preparation
or in an article poses a risk to human health or the environment that is not adequately controlled and needs to be addressed
it shall notify the Agency that it proposes to prepare a dossier which conforms to the requirements of the relevant sections of Annex XV. If the substance is not on the list maintained by the Agency referred to in paragraph 5 of this Article, the Member State shall prepare a dossier which conforms to the requirements of
Annex XV within 12 months of the notification to the Agency. If this dossier demonstrates that action on a Community-wide basis is necessary, beyond any measures already in place, the
Member State shall submit it to the Agency in the format outlined in Annex XV, in order to initiate the restrictions process.
The Agency or Member States shall refer to any dossier, chemical safety report or risk assessment submitted to the Agency or Member State under this Regulation. The Agency or Member States shall also refer to any relevant risk assessment submitted for the purposes of other Community Regulations or Directives.
To this end other bodies, such as agencies, established under Community law and carrying out a similar task shall provide information to the Agency or Member State concerned on request.
The Committee for Risk Assessment and the Committee for Socio-economic Analysis shall check whether the dossier submitted conforms to the requirements of Annex XV. Within 30 days of receipt, the respective Committee shall inform the Agency or the Member State suggesting restrictions, as to whether the dossier conforms. If the dossier does not conform, the reasons
shall be given to the Agency or the Member State in writing within 45 days of receipt. The Agency or the Member State shall bring the dossier into conformity within 60 days of the date of receipt of the reasons from the
Committees, otherwise the procedure under this Chapter shall be terminated. The Agency shall publish without delay the intention of the Commission or of a Member State to instigate a restriction procedure for a substance and shall inform those who submitted a registration for that substance.
5. The Agency shall maintain a list of substances for which a dossier conforming to the requirements of Annex XV is planned or underway by either the Agency or a Member State for the purposes of a proposed restriction. If a substance is on the list, no other such dossier shall be prepared. If it is proposed by either a Member State or the
Agency that an existing restriction listed in Annex XVII should be re-examined a decision on whether to do so shall be taken in accordance with the procedure referred to in Article
133(2) based on evidence presented by the Member State or the Agency.
6. Without prejudice to Articles 118 and 119, the Agency shall make publicly available on its website all dossiers conforming with Annex XV including the restrictions suggested pursuant to paragraphs 3 and 4 of this Article without delay, clearly indicating the
date of publication. The Agency shall invite all interested parties to submit individually or jointly within six months of the date of publication:
(a) comments on dossiers and the suggested restrictions;
(b) a socio-economic analysis, or information which can contribute to one, of the suggested restrictions, examining the advantages and drawbacks
of the proposed restrictions. It shall conform to the requirements in Annex XVI.
- Referred by:
- ARTICLE 42: Check of information submitted and follow-up to dossier evaluation
- ARTICLE 48: Follow-up to substance evaluation
- ARTICLE 50: Registrants' and downstream users' rights
- ARTICLE 68: Introducing new and amending current restrictions
- ARTICLE 70: Agency opinion: Committee for Risk Assessment
- ARTICLE 71: Agency opinion: Committee for Socio-economic Analysis
- ARTICLE 136: Transitional measures regarding existing substances
- ARTICLE XVI: SOCIO-ECONOMIC ANALYSIS